1. Home
  2. Directory
  3. Illinois
  4. Oak Lawn
  5. Psychiatry Neurology
  6. NPI Profile
  7. Prescriptions 1982167730

DR. DARRIAN D MURPHY MD
Prescription History 1982167730
Psychiatry & Neurology - Child & Adolescent Psychiatry in Oak Lawn, IL

NPI Status: Active since April 09, 2019

Contact Information

4440 W 95TH ST
OAK LAWN, IL
ZIP 60453
Phone: (708) 684-8000

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. DARRIAN D MURPHY MD, an active Child & Adolescent Psychiatry specialist practicing in Oak Lawn, IL. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 124 documented patient claims. Among these therapy options, the most frequently utilized medication is Mirtazapine, which accounts for 27 claims alone.

Medication Index

B
C
H
L
M
No matching medications currently found on file.

Buspirone Hcl

Generic Formulation: Buspirone HclSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 19
30-Day Fills 39.0
Days Supply 1,170
IL State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills60.8
Peer Average Days Supply1,718
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 54.8% less volume than the regional standard for practitioners inside IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $188.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.91

State Avg Cost Per Claim

$18.24

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat anxiety. It may help you think more clearly, relax, worry less, and take part in everyday life. It may also help you to feel less jittery and irritable, and may control symptoms such as trouble sleeping, sweating, and pounding heartbeat. Buspirone is a medication for anxiety (anxiolytic) that works by affecting certain natural substances in the brain (neurotransmitters).

Clonazepam

Generic Formulation: ClonazepamSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 24
30-Day Fills 24.0
Days Supply 362
IL State Average Benchmarks
Peer Average Claims49.0
Peer Average 30-Day Fills57.3
Peer Average Days Supply1,631
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 51.0% less volume than the regional standard for practitioners inside IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $27.79 across this reporting matrix range.

Provider Avg Cost Per Claim

$1.16

State Avg Cost Per Claim

$9.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.

Therapeutic Applications

Clonazepam is used to prevent and control seizures. This medication is known as an anticonvulsant or antiepileptic drug. It is also used to treat panic attacks. Clonazepam works by calming your brain and nerves. It belongs to a class of drugs called benzodiazepines.

Hydroxyzine Hcl

Generic Formulation: Hydroxyzine HclSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 16
30-Day Fills 20.0
Days Supply 600
IL State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills36.7
Peer Average Days Supply945
Conservative Utilization

This provider writes prescriptions for this formulation 44.8% less frequently than the standard regional baseline metric for practitioners inside IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $324.21 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.26

State Avg Cost Per Claim

$21.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Hydroxyzine is used to treat itching caused by allergies. It is an antihistamine and works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Hydroxyzine may also be used short-term to treat anxiety or to help you feel sleepy/relaxed before and after surgery.

Lamotrigine

Generic Formulation: LamotrigineSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 24
30-Day Fills 28.0
Days Supply 840
IL State Average Benchmarks
Peer Average Claims50.0
Peer Average 30-Day Fills75.4
Peer Average Days Supply2,163
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 52.0% less volume than the regional standard for practitioners inside IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $171.91 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.16

State Avg Cost Per Claim

$16.67

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER.

Therapeutic Applications

Lamotrigine is used alone or with other medications to prevent and control seizures. It may also be used to help prevent the extreme mood swings of bipolar disorder in adults. Lamotrigine is known as an anticonvulsant or antiepileptic drug. It is thought to work by restoring the balance of certain natural substances in the brain. This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections).

Lurasidone Hcl

Generic Formulation: Lurasidone HclSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.0
Days Supply 420
IL State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$533.92

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Mirtazapine

Generic Formulation: MirtazapineSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 27
30-Day Fills 29.0
Days Supply 870
IL State Average Benchmarks
Peer Average Claims49.0
Peer Average 30-Day Fills68.8
Peer Average Days Supply1,880
Conservative Utilization

This provider writes prescriptions for this formulation 44.9% less frequently than the standard regional baseline metric for practitioners inside IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $222.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.25

State Avg Cost Per Claim

$23.00

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Therapeutic Applications

Mirtazapine is used to treat depression. It improves mood and feelings of well-being. Mirtazapine is an antidepressant that works by restoring the balance of natural chemicals (neurotransmitters) in the brain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. DARRIAN D MURPHY MD provides transparency into local medical care patterns within Oak Lawn, IL.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Child & Adolescent Psychiatry** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.